Core Points - Catheter Precision, Inc. has executed a 1-for-19 reverse stock split effective August 15, 2025, with trading continuing under the symbol "VTAK" on a split-adjusted basis [1][2] - The reverse stock split will reduce the number of issued shares from approximately 23,316,520 to about 1,657,640 shares [4] - Stockholders will not receive fractional shares; instead, they will receive a pro rata portion of the net proceeds from the sale of fractional shares [3] Company Details - The reverse stock split will not change the par value per share and will affect all stockholders uniformly [2][3] - Stockholders holding shares in brokerage accounts should direct inquiries to their brokers, while all stockholders of record can contact the Company's transfer agent for assistance [4] - Additional information regarding the reverse stock split is available in the Company's definitive proxy statement filed with the SEC [5]